229 related articles for article (PubMed ID: 22836768)
21. DJ-1 plays an important role in caffeic acid-mediated protection of the gastrointestinal mucosa against ketoprofen-induced oxidative damage.
Cheng YT; Ho CY; Jhang JJ; Lu CC; Yen GC
J Nutr Biochem; 2014 Oct; 25(10):1045-57. PubMed ID: 25037998
[TBL] [Abstract][Full Text] [Related]
22. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.
Im JY; Lee KW; Woo JM; Junn E; Mouradian MM
Hum Mol Genet; 2012 Jul; 21(13):3013-24. PubMed ID: 22492997
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of DNA repair genes in Fuchs endothelial corneal dystrophy.
Ashraf S; Deshpande N; Vasanth S; Melangath G; Wong RJ; Zhao Y; Price MO; Price FW; Jurkunas UV
Exp Eye Res; 2023 Jun; 231():109499. PubMed ID: 37169279
[TBL] [Abstract][Full Text] [Related]
24. Trinucleotide Repeat Expansion in the Transcription Factor 4 (TCF4) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy.
Wieben ED; Aleff RA; Tang X; Butz ML; Kalari KR; Highsmith EW; Jen J; Vasmatzis G; Patel SV; Maguire LJ; Baratz KH; Fautsch MP
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):343-352. PubMed ID: 28118661
[TBL] [Abstract][Full Text] [Related]
25. Increased Corneal Endothelial Cell Migration in Fuchs Endothelial Corneal Dystrophy: A Live Cell Imaging Study.
Ong Tone S; Wylegala A; Böhm M; Melangath G; Deshpande N; Jurkunas UV
Ophthalmol Sci; 2021 Mar; 1(1):100006. PubMed ID: 36246012
[TBL] [Abstract][Full Text] [Related]
26. TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.
Mootha VV; Hussain I; Cunnusamy K; Graham E; Gong X; Neelam S; Xing C; Kittler R; Petroll WM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):2003-11. PubMed ID: 25722209
[TBL] [Abstract][Full Text] [Related]
27. L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy.
Meng H; Matthaei M; Ramanan N; Grebe R; Chakravarti S; Speck CL; Kimos M; Vij N; Eberhart CG; Jun AS
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1887-97. PubMed ID: 23422828
[TBL] [Abstract][Full Text] [Related]
28. A short-term in vivo experimental model for Fuchs endothelial corneal dystrophy.
Haydari MN; Perron MC; Laprise S; Roy O; Cameron JD; Proulx S; Brunette I
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6343-54. PubMed ID: 22915029
[TBL] [Abstract][Full Text] [Related]
29. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy.
Gottsch JD; Bowers AL; Margulies EH; Seitzman GD; Kim SW; Saha S; Jun AS; Stark WJ; Liu SH
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):594-9. PubMed ID: 12556388
[TBL] [Abstract][Full Text] [Related]
30. Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.
Ong Tone S; Kocaba V; Böhm M; Wylegala A; White TL; Jurkunas UV
Prog Retin Eye Res; 2021 Jan; 80():100863. PubMed ID: 32438095
[TBL] [Abstract][Full Text] [Related]
31. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of the TCF4 Isoform in Corneal Endothelial Cells of Patients With Fuchs Endothelial Corneal Dystrophy.
Honda T; Nakagawa T; Yuasa T; Tokuda Y; Nakano M; Tashiro K; Tourtas T; Schlötzer-Schrehardt U; Kruse F; Yamamoto K; Koizumi N; Okumura N
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):27. PubMed ID: 38884552
[TBL] [Abstract][Full Text] [Related]
33. Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction.
Ward KW
Curr Opin Pharmacol; 2024 Feb; 74():102429. PubMed ID: 38171062
[TBL] [Abstract][Full Text] [Related]
34. UV-A Irradiation Activates Nrf2-Regulated Antioxidant Defense and Induces p53/Caspase3-Dependent Apoptosis in Corneal Endothelial Cells.
Liu C; Vojnovic D; Kochevar IE; Jurkunas UV
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2319-27. PubMed ID: 27127932
[TBL] [Abstract][Full Text] [Related]
35. Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy.
De Roo AK; Wouters J; Govaere O; Foets B; van den Oord JJ
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):670-681. PubMed ID: 28135362
[TBL] [Abstract][Full Text] [Related]
36. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis.
Jun AS; Meng H; Ramanan N; Matthaei M; Chakravarti S; Bonshek R; Black GC; Grebe R; Kimos M
Hum Mol Genet; 2012 Jan; 21(2):384-93. PubMed ID: 22002996
[TBL] [Abstract][Full Text] [Related]
37. Functional impact of ZEB1 mutations associated with posterior polymorphous and Fuchs' endothelial corneal dystrophies.
Chung DW; Frausto RF; Ann LB; Jang MS; Aldave AJ
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6159-66. PubMed ID: 25190660
[TBL] [Abstract][Full Text] [Related]
38. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
[TBL] [Abstract][Full Text] [Related]
39. Restoration of Mitochondrial Integrity, Telomere Length, and Sensitivity to Oxidation by In Vitro Culture of Fuchs' Endothelial Corneal Dystrophy Cells.
Gendron SP; Thériault M; Proulx S; Brunette I; Rochette PJ
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):5926-5934. PubMed ID: 27802523
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes.
Lee E; Yin Z; Sidoryk-Węgrzynowicz M; Jiang H; Aschner M
Free Radic Biol Med; 2012 Mar; 52(6):1067-74. PubMed ID: 22245093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
